Delivery Order SPE2DB20D3103-SPE2DB22FN8D2

Award Date 6/3/22
Potential Completion Date 6/6/22
Potential Value $4.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,407.98, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product Trulicity 1.5 mg/0.5 mL pen, 0.5 mL. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $97,755.58 Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract provides for the supply of Trulicity 1.5 mg/0.5 ml pens to support military healthcare programs. The IDC, valued at up to $999,999,999, serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,479.83 and covers the supply of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen. The award is part of a larger $999,999,999 IDC held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,741.68 for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 14, 2023. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) valued at $1,948.44. The award was made by the Defense Logistics Agency (DLA) for the supply of the pharmaceutical product Trulicity 3 mg/0.5 ml pen. The IDC held by Cencora, Inc. with the DLA Troop Support Medical is valued at up to $999,999,999.00 and serves as the primary vehicle for the company to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The award, valued at $10,320.21, is for the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen, 0.5 ml. This order supports military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The DLA Troop Support Medical IDC, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,662.08 for the pharmaceutical product Trulicity 3 mg/0.5 ml pen. The contract is administered by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 21, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,560.60 for the pharmaceutical product Trulicity (0.75 mg/0.5 ml pen 0.5 ml). The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD), and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $6,966.72 for the pharmaceutical product Trulicity 3 mg/0.5 ml pen 0.5 ml. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 4, 2023. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,403.02 for the pharmaceutical product Trulicity 3 mg/0.5 ml pen. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 21, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FN8D2
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The $4,377.39 contract is for the supply of the pharmaceutical product Trulicity 3 mg/0.5 ml pen. This award is part of a $999,999,999 single-award IDC held by Cencora, Inc. with the DLA, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA IDC, Cencora, Inc. also holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 12:11 PM